Additionally, the Dahuang Zhechong pill ameliorated CCl4-induced liver fibrosis by reducing the protein levels of PI3K and phosphorylated AKT and inhibiting the proliferation of HSC, and exerting a synergistic effect with the PI3K inhibitor LY294002. The gene discussed is AKT1; the disease is Hepatic fibrosis.